Our results in the liver also confirmed that BCL2L11 expression was significantly downregulated, while NAGS, HDHD3 and RMND1 expression levels were significantly upregulated in NAFLD. This evidence concerns the gene NAGS and metabolic dysfunction-associated steatotic liver disease.